Overall, our data reveal multiple cellular abnormalities in FAHN, highlighting diminished FA2H protein levels and altered expression in mutant proteins in both neuronal and oligodendrocyte cells. The gene discussed is FA2H; the disease is fatty acid hydroxylase-associated neurodegeneration.